Warfarin, dabigatran and rivaroxaban are safe periprocedural anticoagulation options for patients undergoing cardioversion or ablation for atrial fibrillation, according to researchers in Canada. “We ...

Maze surgery, or surgical ablation, is a procedure commonly recommended to treat an irregular heartbeat (atrial fibrillation) when other methods such as medication, cardioversion therapy (electric ...

Ann Arbor, MI - A new study evaluating the potential of catheter ablation for the treatment of chronic atrial fibrillation (AF) has shown that sinus rhythm can be maintained long term in a majority of ...

Hitoshi Ichiki, M.D.; Naoya Oketani, M.D.; Sanemasa Ishida, M.D.; Yasuhisa Iriki, M.D.; Hideki Okui, M.D.; Ryuichi Maenosono, M.T.; Fuminori Namino, M.T.; Yuichi ...

Patients undergoing radiofrequency ablation to treat a heart rhythm problem known as atrial fibrillation (AF) have better early outcomes if they take the drug amiodarone immediately after their ...

image: Anticoagulant therapy is important for stroke prevention in people with atrial fibrillation, but a new study shows many people don't stick with it. view more For patients with atrial ...

Left atrial (LA) thrombus is not infrequently found in patients with atrial fibrillation (AF) or flutter who have been taking oral anticoagulation continuously for at least 3 weeks, a meta-analysis ...

Please provide your email address to receive an email when new articles are posted on . After atrial fibrillation ablation, dronedarone was associated with lower risk for recurrent hospitalizations ...

Compared with medical therapy, rhythm control with catheter ablation is associated with lower risk of ischemic stroke after 30 days, as well as less mortality and heart failure (HF) hospitalization, ...

People with atrial fibrillation have a reduced risk of dementia if they undergo a procedure called catheter ablation to restore the normal rhythm of their heart, according to a new study published ...

Atrial fibrillation (AF) is the most prevalent sustained arrhythmia in Canada, with a prevalence exceeding 15% among people older than 60 years, increasing stroke risk and health care utilization.